Destelbergen, Belgium

Frederik Deroose

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Frederik Deroose

Introduction

Frederik Deroose is a notable inventor based in Destelbergen, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for IDO1, a target in cancer treatment.

Latest Patents

Deroose holds five patents, with his latest innovations focusing on treatment methods utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors. These compounds, described in his patents, are useful for the treatment and prevention of cancer and endometriosis. The patents detail the uses of compounds of Formula I, including their pharmaceutically acceptable enantiomers, salts, solvates, or prodrugs.

Career Highlights

Throughout his career, Deroose has worked with Iteos Therapeutics, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His work has been pivotal in advancing therapeutic options for patients suffering from serious health conditions.

Collaborations

Deroose has collaborated with esteemed colleagues such as Stefano Crosignani and Sandra Cauwenberghs, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Frederik Deroose's innovative work in developing IDO1 inhibitors showcases his commitment to advancing medical science. His contributions are vital in the ongoing fight against cancer and endometriosis, marking him as a significant figure in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…